Jeffrey L Sklar
Overview
Explore the profile of Jeffrey L Sklar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gibson J, Finberg K, Nalbantoglu I, Cecchini M, Ganzak A, Walther Z, et al.
Lancet Oncol
. 2021 Mar;
22(3):306-307.
PMID: 33662283
No abstract available.
2.
Stewart T, Finberg K, Walther Z, Sklar J, Hafez N, Eder J, et al.
Lancet Oncol
. 2020 Sep;
19(12):1567-1568.
PMID: 32956641
No abstract available.
3.
Hafez N, Walther Z, Eder J, Sklar J, Gettinger S, Finberg K, et al.
Lancet Oncol
. 2020 Sep;
21(3):343-344.
PMID: 32950226
No abstract available.
4.
Maracaja D, Puthenpura V, Pels S, OMalley D, Sklar J, Finberg K, et al.
Appl Immunohistochem Mol Morphol
. 2019 Dec;
28(10):725-730.
PMID: 31789821
Primary mediastinal (thymic) large B-cell lymphoma (PMBL) is described as almost always negative for Epstein-Barr virus (EBV). In the context of a mediastinal lymphoma, the distinction between PMBL, classical Hodgkin...
5.
Cecchini M, Walther Z, Sklar J, Bindra R, Petrylak D, Eder J, et al.
Lancet Oncol
. 2018 Jan;
19(1):23-24.
PMID: 29304353
No abstract available.
6.
Cecchini M, Walther Z, Sklar J, Bindra R, Petrylak D, Eder J, et al.
Lancet Oncol
. 2018 Jan;
19(1):19-20.
PMID: 29304351
No abstract available.
7.
Lih C, Harrington R, Sims D, Harper K, Bouk C, Datta V, et al.
J Mol Diagn
. 2017 Feb;
19(2):313-327.
PMID: 28188106
The National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) trial is a national signal-finding precision medicine study that relies on genomic assays to screen and enroll patients with relapsed or...
8.
Ma X, Wang J, Wang J, Ma C, Gao X, Patriub V, et al.
Oncotarget
. 2016 Nov;
8(3):4062-4078.
PMID: 27845897
The Polycomb repressive complex 2 (PRC2), which contains three core proteins EZH2, EED and SUZ12, controls chromatin compaction and transcription repression through trimethylation of lysine 27 on histone 3. The...